SGCB and diabetic kidney disease: A study in Germany induced a DKD animal model using STZ in endothelial NOS (eNOS) knockout mice, where a combination of the sGC stimulator riociguat and angiotensin receptor blockers (ARBs) telmisartan reduced urinary protein excretion.